1. Home
  2. GNFT vs AIRS Comparison

GNFT vs AIRS Comparison

Compare GNFT & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • AIRS
  • Stock Information
  • Founded
  • GNFT 1999
  • AIRS 2012
  • Country
  • GNFT France
  • AIRS United States
  • Employees
  • GNFT N/A
  • AIRS N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • AIRS Medical/Nursing Services
  • Sector
  • GNFT Health Care
  • AIRS Health Care
  • Exchange
  • GNFT Nasdaq
  • AIRS Nasdaq
  • Market Cap
  • GNFT 214.5M
  • AIRS 166.3M
  • IPO Year
  • GNFT 2019
  • AIRS 2021
  • Fundamental
  • Price
  • GNFT N/A
  • AIRS $5.25
  • Analyst Decision
  • GNFT Strong Buy
  • AIRS Hold
  • Analyst Count
  • GNFT 1
  • AIRS 3
  • Target Price
  • GNFT $13.00
  • AIRS $3.75
  • AVG Volume (30 Days)
  • GNFT 4.2K
  • AIRS 788.4K
  • Earning Date
  • GNFT 04-24-2025
  • AIRS 08-08-2025
  • Dividend Yield
  • GNFT N/A
  • AIRS N/A
  • EPS Growth
  • GNFT N/A
  • AIRS N/A
  • EPS
  • GNFT 0.03
  • AIRS N/A
  • Revenue
  • GNFT $73,187,701.00
  • AIRS $172,101,000.00
  • Revenue This Year
  • GNFT $15.98
  • AIRS N/A
  • Revenue Next Year
  • GNFT N/A
  • AIRS $4.90
  • P/E Ratio
  • GNFT $125.14
  • AIRS N/A
  • Revenue Growth
  • GNFT 105.01
  • AIRS N/A
  • 52 Week Low
  • GNFT $2.55
  • AIRS $1.53
  • 52 Week High
  • GNFT $6.42
  • AIRS $9.20
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 46.56
  • AIRS 64.29
  • Support Level
  • GNFT $3.61
  • AIRS $4.70
  • Resistance Level
  • GNFT $3.95
  • AIRS $5.40
  • Average True Range (ATR)
  • GNFT 0.14
  • AIRS 0.42
  • MACD
  • GNFT -0.01
  • AIRS -0.03
  • Stochastic Oscillator
  • GNFT 50.64
  • AIRS 94.23

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.

Share on Social Networks: